The device was not received for evaluation; therefore, a device analysis could not be completed.However, upon follow up the reporter stated that "they have ruled out the compounder being at fault" for this event.Should additional relevant information become available, a supplemental report will be submitted.
|
It was reported a neonate patient experienced hyperglycemia, after receiving an intravenous infusion of total parenteral nutrition (tpn).The tpn order was created using an exactamix automated compounder device.It was further reported prior to administration of the tpn, the patient had normal glucose levels.Approximately 20 minutes after receiving tpn, patient blood glucose was taken and it was spiking".The infusion rate was decreased and 30 minutes later, the blood glucose levels were in the 500 range¿.The tpn was removed and ¿a starter tpn¿ was administered.The patient glucose levels returned ¿back to normal¿ by the next day.At the time of this report, the patient was in stable condition.No additional information is available.
|